LAKEESHA MILLER: Open Payments
NPI 1124803606 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,682 in 162 payments from 25 companies in 2025. Trend: 2023 $556 · 2024 $2,797 · 2025 $3,682
Food & beverage: $3,622Education: $60
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $787 |
| GlaxoSmithKline, LLC. | 30 | $529 |
| GENZYME CORPORATION | 16 | $398 |
| Regeneron Healthcare Solutions, Inc. | 16 | $315 |
| Insmed, Inc. | 12 | $204 |
| United Therapeutics Corporation | 8 | $192 |
| Merck Sharp & Dohme LLC | 6 | $154 |
| Viatris Specialty LLC | 7 | $138 |
| Verona Pharma, Inc. | 6 | $117 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $115 |
Products named: DUPIXENT, NUCALA, Tyvaso, BREZTRI, AIRSUPRA, Arikayce, ZERBAXA, YUPELRI.
Industry payments across NC — which companies pay providers there.
